C. McLaren

3.8k total citations
69 papers, 2.9k citations indexed

About

C. McLaren is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, C. McLaren has authored 69 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Epidemiology, 28 papers in Immunology and 23 papers in Infectious Diseases. Recurrent topics in C. McLaren's work include Influenza Virus Research Studies (31 papers), HIV/AIDS drug development and treatment (21 papers) and Immune Response and Inflammation (19 papers). C. McLaren is often cited by papers focused on Influenza Virus Research Studies (31 papers), HIV/AIDS drug development and treatment (21 papers) and Immune Response and Inflammation (19 papers). C. McLaren collaborates with scholars based in United States, United Kingdom and Germany. C. McLaren's co-authors include C. W. Potter, David W. Barry, R. Jennings, Mark Ellis, Raphael Dolin, J D Meyers, James C. Wade, Fred Valentine, Rein Saral and Richard C. Reichman and has published in prestigious journals such as New England Journal of Medicine, The Lancet and The Journal of Immunology.

In The Last Decade

C. McLaren

69 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. McLaren United States	26	1.6k	1.4k	1.1k	540	330	69	2.9k
M. Dietrich Germany	24	779 0.5×	1.1k 0.8×	963 0.9×	645 1.2×	152 0.5×	70	2.7k
Patricia Barditch‐Crovo United States	17	635 0.4×	1.7k 1.2×	2.0k 1.9×	691 1.3×	320 1.0×	27	3.0k
Ruy Soeiro United States	21	736 0.5×	1.0k 0.7×	800 0.8×	204 0.4×	901 2.7×	33	2.6k
Clyde S. Crumpacker United States	25	1.6k 1.0×	935 0.7×	885 0.8×	268 0.5×	162 0.5×	40	2.6k
R V Srinivas United States	25	568 0.4×	1.0k 0.7×	911 0.9×	308 0.6×	729 2.2×	58	2.4k
Salvatore T. Butera United States	29	782 0.5×	1.2k 0.9×	1.9k 1.8×	975 1.8×	588 1.8×	58	2.8k
Douglas L. Mayers United States	30	802 0.5×	2.9k 2.0×	2.5k 2.4×	311 0.6×	335 1.0×	90	3.9k
Georgios Pollakis Netherlands	29	785 0.5×	1.1k 0.8×	1.7k 1.6×	920 1.7×	685 2.1×	95	2.9k
Jan Karel M. Eeftinck Schattenkerk Netherlands	24	849 0.5×	1.3k 0.9×	1.6k 1.5×	880 1.6×	162 0.5×	36	2.8k
Christos Tsoukas Canada	26	840 0.5×	1.2k 0.8×	1.1k 1.1×	838 1.6×	167 0.5×	93	2.6k

Countries citing papers authored by C. McLaren

Since Specialization

Citations

This map shows the geographic impact of C. McLaren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. McLaren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. McLaren more than expected).

Fields of papers citing papers by C. McLaren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. McLaren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. McLaren. The network helps show where C. McLaren may publish in the future.

Co-authorship network of co-authors of C. McLaren

This figure shows the co-authorship network connecting the top 25 collaborators of C. McLaren. A scholar is included among the top collaborators of C. McLaren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. McLaren. C. McLaren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gathe, Joseph, et al.. (2002). Antiviral Activity of Enteric-Coated Didanosine, Stavudine, and Nelfinavir Versus Zidovudine Plus Lamivudine and Nelfinavir. JAIDS Journal of Acquired Immune Deficiency Syndromes. 31(4). 399–403. 14 indexed citations

Pollard, Richard B., et al.. (1999). Virological and immunological responses to once-daily dosing of didanosine in combination with stavudine. AIDS. 13(11). F87–F93. 22 indexed citations

McLaren, C., et al.. (1997). Text and Illustration: The digitisation of a Medieval Manuscript. Computers and the Humanities. 31(1). 61–71. 2 indexed citations

Welles, Seth L., J. Brooks Jackson, Belinda Yen‐Lieberman, et al.. (1996). Prognostic Value of Plasma Human Immunodeficiency Virus Type 1 (HIV-l) RNA Levels in Patients with Advanced HIV-l Disease and with Little or No Prior Zidovudine Therapy. The Journal of Infectious Diseases. 174(4). 696–703. 74 indexed citations

Japour, Anthony J., Juan J.L. Lertora, Alejo Erice, et al.. (1996). A Phase-I Study of the Safety, Pharmacokinetics, and Antiviral Activity of Combination Didanosine and Ribavirin in Patients with HIV-1 Disease. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 13(3). 235–246. 34 indexed citations

McLaren, C., et al.. (1996). Inter-Company Collaboration for AIDS Drug Development: perspective on combination studies. Antiviral Research. 29(1). 119–122. 1 indexed citations

Allan, J. Davis, et al.. (1993). Long-Term Follow-Up of Didanosine Administered Orally Twice Daily to Patients with Advanced Human Immunodeficiency Virus Infection and Hematologic Intolerance of Zidovudine. Clinical Infectious Diseases. 16(Supplement_1). S46–S51. 19 indexed citations

McLaren, C., Marcel Rozencweig, Mohan Beltangady, et al.. (1993). Longitudinal Analysis of Responses to Oral Didanosine Therapy Following Zidovudine Therapy in Advanced Infection with Human Immunodeficiency Virus. Clinical Infectious Diseases. 16(Supplement_1). S32–S39. 3 indexed citations

Pai, Sudhakar M., Umesh Shukla, Thaddeus H. Grasela, et al.. (1992). Population Pharmacokinetic Analysis of Didanosine (2′,3′‐Dideoxyinosine) Plasma Concentrations Obtained in Phase I Clinical Trials in Patients with AIDS or AIDS‐Related Complex. The Journal of Clinical Pharmacology. 32(3). 242–247. 21 indexed citations

10.

Knupp, Catherine A., Wen Chyi Shyu, Raphael Dolin, et al.. (1991). Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome—related complex. Clinical Pharmacology & Therapeutics. 49(5). 523–535. 89 indexed citations

11.

Connolly, Kevin, et al.. (1991). Phase I study of 2′-3′-dideoxyinosine administered orally twice daily to patients with AIDS or AIDS-related complex and hematologic intolerance to zidovudine. The American Journal of Medicine. 91(5). 471–478. 53 indexed citations

12.

McLaren, C., et al.. (1991). Didanosine. Antiviral chemistry & chemotherapy. 2(6). 321–328. 17 indexed citations

13.

Cooley, Timothy P., Laureen M. Kunches, Susan L. Kelley, et al.. (1990). Treatment of AIDS and AIDS-Related Complex with 2′,3′-Dideoxyinosine Given Once Daily. Clinical Infectious Diseases. 12(Supplement_5). S552–S560. 35 indexed citations

14.

Lambert, John S., Mindell Seidlin, Richard C. Reichman, et al.. (1990). 2′,3′-Dideoxyinosine (ddI) in Patients with the Acquired Immunodeficiency Syndrome or AIDS-Related Complex. New England Journal of Medicine. 322(19). 1333–1340. 318 indexed citations

15.

McLaren, C., et al.. (1977). Serological responses to whole and split A/New Jersey vaccines in humans and mice following priming infection with influenza A viruses.. PubMed. 39. 261–6. 4 indexed citations

16.

McLaren, C., et al.. (1976). Lymphocyte and macrophage responses after vaccinia virus infections. Infection and Immunity. 14(4). 1014–1021. 15 indexed citations

17.

Jennings, R., et al.. (1975). A new, surface-antigen-adsorbed influenza virus vaccine. I. Studies on immunogenicity in hamsters. Journal of Hygiene. 75(3). 341–352. 10 indexed citations

18.

Potter, C. W., C. McLaren, & Steven L. Shore. (1973). Immunity to influenza in ferrets V. Immunization with inactivated virus in adjuvant 65. Journal of Hygiene. 71(1). 97–106. 12 indexed citations

19.

Shore, Steven L., C. W. Potter, & C. McLaren. (1972). Immunity to Influenza in Ferrets. IV. Antibody in Nasal Secretions. The Journal of Infectious Diseases. 126(4). 394–400. 16 indexed citations

20.

Oxford, John, C. W. Potter, C. McLaren, & William D. Hardy. (1971). Inactivation of Influenza and Other Viruses by a Mixture of Virucidal Compounds. Applied Microbiology. 21(4). 606–610. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact